FAM35A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.153000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.137800E-01
Normal-vs-Stage2
3.438000E-01
Normal-vs-Stage3
3.817800E-02
Normal-vs-Stage4
4.779200E-01
Stage1-vs-Stage2
3.249000E-01
Stage1-vs-Stage3
2.478400E-02
Stage1-vs-Stage4
5.751800E-01
Stage2-vs-Stage3
1.918170E-01
Stage2-vs-Stage4
7.581800E-01
Stage3-vs-Stage4
1.629430E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.697200E-01
Normal-vs-AfricanAmerican
8.613400E-01
Normal-vs-Asian
7.382600E-01
Caucasian-vs-AfricanAmerican
2.036000E-01
Caucasian-vs-Asian
2.875600E-01
AfricanAmerican-vs-Asian
7.834200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.847400E-01
Normal-vs-Female
2.369800E-01
Male-vs-Female
7.757600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.338640E-01
Normal-vs-Age(41-60Yrs)
5.066800E-01
Normal-vs-Age(61-80Yrs)
2.558600E-01
Normal-vs-Age(81-100Yrs)
2.866800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.383800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.149000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.568000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.231700E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.106800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.806400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.427200E-01
Normal-vs-Daily Drinker
2.515600E-01
Normal-vs-Weekly Drinker
8.040200E-01
Normal-vs-Occasional Drinker
2.991800E-01
Normal-vs-Social Drinker
3.436800E-01
Non Drinker-vs-Daily Drinker
8.642400E-01
Non Drinker-vs-Weekly Drinker
1.715780E-01
Non Drinker-vs-Occasional Drinker
7.447400E-01
Non Drinker-vs-Social Drinker
5.287200E-01
Daily Drinker-vs-Weekly Drinker
1.782370E-01
Daily Drinker-vs-Occasional Drinker
6.547200E-01
Daily Drinker-vs-Social Drinker
4.717400E-01
Weekly Drinker-vs-Occasional Drinker
3.188600E-01
Weekly Drinker-vs-Social Drinker
4.585000E-01
Occasional Drinker-vs-Social Drinker
7.636800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.310800E-01
Normal-vs-Grade 2
7.038800E-01
Normal-vs-Grade 3
7.170000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.808100E-02
Grade 1-vs-Grade 3
7.818200E-02
Grade 1-vs-Grade 4
8.310800E-01
Grade 2-vs-Grade 3
7.722600E-01
Grade 2-vs-Grade 4
7.038800E-01
Grade 3-vs-Grade 4
7.170000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.691430E-01
Normal-vs-NonDiabetic
3.118600E-01
Diabetic-vs-NonDiabetic
2.713000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.502400E-01
Normal-vs-NoPancreatitis
2.920600E-01
Pancreatitis-vs-NoPancreatitis
6.360200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.874000E-01
Normal-vs-N1
3.460800E-01
N0-vs-N1
9.141800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.208600E-01
Normal-vs-TP53-NonMutant
7.902000E-01
TP53-Mutant-vs-TP53-NonMutant
1.728990E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
